Researchers reveal brain parasites could be used to treat cognitive disorders
Neurological conditions, including Alzheimer’s disease, are the leading cause of ill health globally
Read More
Tag: Toxoplasma gondii
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
